alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NEX SEF-2018-R-10

November 2, 2018

Submitted via CFTC Portal

Division of Market Oversight

U.S. Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, D.C. 20581

Re: NEX SEF Limited – Regulation 40.6 Rule Certification – Amended Rulebook

Ladies and Gentlemen:

Pursuant to Section 5c(c) of the Commodity Exchange Act (the “Act”) and Section 40.6(a) of the 

regulations of the Commodity Futures Trading Commission (the “Commission”), NEX SEF Limited (“NEX 

SEF” or the “Facility”) hereby notifies the Commission that it has amended its Rulebook, specifically Rule 

802(1). 

A concise explanation and analysis of the amendments to the Rulebook and their compliance with 

applicable provisions of the Act and the Commission’s regulations thereunder is attached hereto as 

Exhibit A. 

A clean copy of the amended Rulebook exclusive of confidential Chapter 9 is attached hereto as Exhibit B

and a copy of the Rulebook exclusive of confidential Chapter 9 marked to show changes against the 

version most recently submitted to the Commission is attached hereto as Exhibit C. 

The amendments will become effective on November 19, 2018. NEX SEF certifies that the amendments 

comply with the requirements of the Act and the rules and regulations promulgated thereunder. NEX SEF

has reviewed the swap execution facility core principles (“Core Principles”) as set forth in the Act and has 

determined that the amendments impact the Core Principles identified in Exhibit A.

NEX SEF is not aware of any substantive opposing views expressed with respect to this filing and 

certifies that, concurrent with this filing, a copy of this submission was posted on the NEX SEF website 

and may be accessed at: http://www.nexsef.com. 

Please contact the undersigned at (212) 521-4609 with any questions regarding this matter.

Very truly yours,

Nirup Ramalingam, Chief Operating Officer

NEX SEF LIMITED

2 Broadgate

London EC2M 7UR

United Kingdom
2

Exhibit A

Explanation and Analysis

NEX SEF has amended its Rulebook as provided below. Capitalized terms used but not defined herein 

have the meanings assigned to them in the Rulebook.

Section/Rule Description of Revision

Reason and/or

Supporting Rule or Core

Principle

Cover Page Updated version number and effective date. Conforming change

Rule 802(1) Rule 802(1) has been amended to specify that Fixed for 

Floating Interest Rate Swaps in SGD are now cleared. 

No other terms and conditions of the Contracts in SGD 

governed by Rule 802(1) have been amended.

 Core Principle 2

 Core Principle 3

ACTIVE 237249285
#### Bailey Credo WITT, Plaintiff-Appellant, v. SNOHOMISH COUNTY WASHINGTON; et al., Defendants-Appellees.

No. 12-35129.

United States Court of Appeals, Ninth Circuit.

Submitted May 14, 2013.*

Filed May 23, 2013.

Bailey Credo Witt, I, Everett, WA, pro se.

*577Sean Donald Reay, Everett, WA, for Defendants-Appellees.

Before: LEAVY, THOMAS, and MURGUIA, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM ***

Bailey Credo Witt appeals pro se from the district court’s summary judgment in his 42 U.S.C. § 1983 action alleging excessive force and illegal search and seizure. We have jurisdiction under 28 U.S.C. § 1291. We review de novo a grant of summary judgment, *Toguchi v. Chung,*391 F.3d 1051, 1056 (9th Cir.2004), and for an abuse of discretion the district court’s decision whether to exclude evidence as a discovery sanction, *Yeti by Molly Ltd. v. Deckers Outdoor Corp.,*259 F.3d 1101, 1105-06 (9th Cir.2001). We affirm.

The district court did not abuse its discretion in refusing to impose discovery sanctions on defendants, as any alleged failure to disclose under Fed.R.Civ.P. 26(a) or (e) was harmless. *See Yeti by Molly Ltd.,*259 F.3d at 1105-06 (explaining that Fed.R.Civ.P. 37 requires the exclusion of evidence unless the failure to disclose was substantially justified or is harmless). Witt’s contention that the failure to exclude the challenged evidence violated his due process rights is unavailing, as the alleged discovery violations had no bearing on Witt’s ability to provide the district court with evidence within his personal knowledge to oppose summary judgment.

Witt’s contention that the district court erred by not granting his request for oral argument is unpersuasive, as the district court was not required to do so under the local rules and, in any event, there is no showing of prejudice. *See Houston v. Bryan,*725 F.2d 516, 518 (9th Cir.1984).

AFFIRMED.

***

 This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
116TH CONGRESS 

1ST SESSION H. R. 2334 

AN ACT 

To designate the Department of Veterans Affairs communitybased outpatient clinic in Odessa, Texas, as the ‘‘Wilson 

and Young Medal of Honor VA Clinic’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 2334 EH

1 SECTION 1. DESIGNATION OF WILSON AND YOUNG MEDAL 

2 OF HONOR VA CLINIC. 

3 (a) FINDING.—Congress finds that Private First 

4 Class Alfred ‘‘Mac’’ Wilson of the Marine Corps and Staff 

5 Sergeant Marvin ‘‘Rex’’ Young of the Army were both 

6 posthumously awarded the Medal of Honor for their heroic 

7 actions in the Vietnam War. 

8 (b) DESIGNATION.—The Department of Veterans Af9 fairs community-based outpatient clinic in Odessa, Texas, 

10 shall after the date of the enactment of this Act be known 

11 and designated as the ‘‘Wilson and Young Medal of Honor 

12 VA Clinic’’. 

13 (c) REFERENCES.—Any reference in a law, map, reg14 ulation, document, paper, or other record of the United 

15 States to the facility referred to in subsection (b) shall 

16 be deemed to be a reference to the ‘‘Wilson and Young 

17 Medal of Honor VA Clinic’’. 

Passed the House of Representatives October 15, 

2019. 

Attest: 

Clerk. 

116TH CONGRESS 

1ST SESSION H. R. 2334 

AN ACT 

To designate the Department of Veterans Affairs 

Honor VA Clinic’’. Texas, as the ‘‘Wilson and Young Medal of community-based outpatient clinic in Odessa,
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2336 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
116th CONGRESS
  1st Session
                                H. R. 2336

_______________________________________________________________________

                                 AN ACT

 
 To amend title 11, United States Code, with respect to the definition 
                         of ``family farmer''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Family Farmer Relief Act of 2019''.

SEC. 2. DEFINITION OF FAMILY FARMER.

    Section 101(18) of title 11, United States Code, is amended by 
striking ``$3,237,000'' each place that term appears and inserting 
``$10,000,000''.

SEC. 3. DETERMINATION OF BUDGETARY EFFECTS.

    The budgetary effects of this Act, for the purpose of complying 
with the Statutory Pay-As-You-Go Act of 2010, shall be determined by 
reference to the latest statement titled ``Budgetary Effects of PAYGO 
Legislation'' for this Act, submitted for printing in the Congressional 
Record by the Chairman of the House Budget Committee, provided that 
such statement has been submitted prior to the vote on passage.

            Passed the House of Representatives July 25, 2019.

            Attest:

                                                                 Clerk.
116th CONGRESS

  1st Session

                               H. R. 2336

_______________________________________________________________________

                                 AN ACT

 To amend title 11, United States Code, with respect to the definition 
                         of ``family farmer''.
```
# C_2019423EN.01001201.xml

| 16.12.2019 | EN | Official Journal of the European Union | C 423/12 |
| --- | --- | --- | --- |

16.12.2019

EN

Official Journal of the European Union

C 423/12

---

Judgment of the Court (Seventh Chamber) of 17 October 2019 (request for a preliminary ruling from the Rechtbank van eerste aanleg te Antwerpen — Belgium) — Argenta Spaarbank NV v Belgische Staat

(Case C-459/18) (1)

(Reference for a preliminary ruling - Tax legislation - Corporation tax - Deduction for risk capital - Reduction of the amount deductible by companies with a permanent establishment in another Member State which generates exempt income under a double taxation convention - Article 49 TFEU - Freedom of establishment - Unfavourable treatment - No such treatment)

(2019/C 423/14)

Language of the case: Dutch

Referring court

Rechtbank van eerste aanleg te Antwerpen

Parties to the main proceedings

Applicant: Argenta Spaarbank NV

Defendant: Belgische Staat

Operative part of the judgment

Article 49 TFEU must be interpreted as not precluding national legislation, such as that at issue in the main proceedings, under which, for the calculation of a deduction granted to a company subject to full tax liability in a Member State and having a permanent establishment in another Member State the income from which is exempt in the first Member State under a double taxation convention, the net value of the assets of such a permanent establishment is taken into account, initially, in the calculation of the deduction for risk capital granted to the resident company, but, subsequently, the amount of the deduction is reduced by the lesser of the following amounts, namely the part of the deduction for risk capital which relates to the permanent establishment or the positive result generated by that permanent establishment, whereas such a reduction is not applied in the case of a permanent establishment situated in the first Member State.

---

(1)  OJ C 373, 15.10.2018.

---
# C_2017231EN.01005402.xml

| 17.7.2017 | EN | Official Journal of the European Union | C 231/54 |
| --- | --- | --- | --- |

17.7.2017

EN

Official Journal of the European Union

C 231/54

---

Order of the General Court of 5 May 2017 — King.com v EUIPO — TeamLava (Onscreen displays and icons)

(Case T-95/17) (1)

1

(2017/C 231/71)

Language of the case: English

The President of the First Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 112, 10.4.2017.

1

---
#### Terrence Bernard HUTCHINS, Petitioner-Appellant, v. Warden Mildred L. RIVERA, Respondent-Appellee.

No. 13-6168.

United States Court of Appeals, Fourth Circuit.

Submitted: April 25, 2013.

Decided: April 30, 2013.

Terrence Hutchins, Appellant Pro Se.

*174Before AGEE and WYNN, Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Terrence Bernard Hutchins, a federal prisoner, appeals the district court’s order accepting the recommendation of the magistrate judge and denying relief on his 28 U.S.C.A. § 2241 (West 2006 & Supp.2012) petition. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. *Hutchins v. Rivera,*No. 8:12-cv-00436-DCN (D.S.C. Jan. 22, 2013). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

*AFFIRMED.*
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Commission on Civil Rights

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights, that a meeting of the New Jersey Advisory Committee to the Commission will convene at 9:30 a.m. and adjourn at 4 p.m. on Wednesday, June 6, 2001, at the New Jersey State House, Room 319, 125 W. State Street, Trenton, New Jersey 08625. The purpose of the meeting is to: (1) review the Committee's draft report on Asian American representation in the New Jersey state government employment; and (2) the Committee will hold a briefing session focusing on the Federal role in compliance with a consent decree remedying racial profiling practices by the New Jersey state police or alternatively criminal prosecutions for civil rights violations in New Jersey.

Persons desiring additional information, or planning a presentation to the Committee, should contact Chairperson Dr. Irene Hill-Smith, 856-468-5546 or Ki-Taek Chun, Director of the Eastern Regional Office, 202-376-7533 (TDD 202-376-8116). Hearing-impaired persons who will attend the meeting and require the services of a sign language interpreter should contact the Regional Office at least ten (10) working days before the scheduled date of the meeting.

The meeting will be conducted pursuant to the provisions of the rules and regulations of the Commission.

Dated at Washington, DC, May 7, 2001.

Edward A. Hailes, Jr.,

General Counsel.

[FR Doc. 01-12442 Filed 5-16-01; 8:45 am]

BILLING CODE 6335-01-P
[Federal Register Volume 66, Number 101 (Thursday, May 24, 2001)]
[Notices]
[Page 28754]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13168]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Pediatric Oncology Subcommittee of the Oncologic 
Drugs Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on June 28, 2001, 8 a.m. to 
5 p.m.
    Location: Center for Drug Evaluation and Research Advisory 
Committee conference room 1066, 5630 Fishers Lane, Rockville, MD.
    Contact Person: Karen M. Templeton-Somers, Center for Drug 
Evaluation and Research, (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7001, or by e-mail: 
<a href="/cdn-cgi/l/email-protection#f7a4989a928584bcb794939285d9919396d9909881"><span class="__cf_email__" data-cfemail="6635090b0314152d26050203144800020748010910">[email protected]</span></a>, or FDA Advisory Committee Information Line, 1-
800-741-8138 (301-443-0572 in the Washington, DC area), code 12542. 
Please call the Information Line for up-to-date information on this 
meeting.
    Agenda: The subcommittee will discuss parameters used for 
extrapolation from the adult to the pediatric setting in solid tumors 
and malignancies of the central nervous system.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the subcommittee. 
Written submissions may be made to the contact person by June 18, 2001. 
Oral presentations from the public will be scheduled between 
approximately 8:15 a.m. and 8:45 a.m., and 1 p.m. and 1:30 p.m. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before June 
18, 2001, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: May 17, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-13168 Filed 5-23-01; 8:45 am]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2019082EN.01005002.xml

| 4.3.2019 | EN | Official Journal of the European Union | C 82/50 |
| --- | --- | --- | --- |

4.3.2019

EN

Official Journal of the European Union

C 82/50

---

Judgment of the General Court of 13 December 2018 — Monster Energy v EUIPO — Bösel (MONSTER DIP)

(Case T-274/17) (1)

((EU trade mark - Opposition proceedings - Application for EU figurative mark MONSTER DIP - Earlier EU word and figurative marks and unregistered sign used in the course of trade, all including the word element ‘monster’ - Relative grounds for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001) - No likelihood of misleading association - Article 8(4) of Regulation No 207/2009 (now Article 8(4) of Regulation 2017/1001) - No likelihood of dilution of the reputation of the earlier mark - Article 8(5) of Regulation No 207/2009 (now Article 8(5) of Regulation 2017/1001)))

(2019/C 82/58)

Language of the case: English

Parties

Applicant: Monster Energy Company (Corona, California, United States) (represented by: P. Brownlow, Solicitor)

Defendant: European Union Intellectual Property Office (represented by: D. Gája, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO: Marco Bösel (Bad Fallingbostel, Germany)

Re:

Action brought against the decision of the Second Board of Appeal of OHIM of 13 December 2016 (Case R 1062/2016-2), relating to opposition proceedings between Monster Energy Company and Marco Bösel.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Monster Energy Company to pay the costs. |
| --- | --- |

2.

Orders Monster Energy Company to pay the costs.

---

(1)  OJ C 221, 10.7.2017.

---
Exhibit 99.1

Statement of Chief Financial Officer

Pursuant to Section 1350 of Title 18 of the United States Code

 

Pursuant to Section 1350 of Title 18 of the United States Code, I, Dale G. Rettinger, the Chief Financial Officer of PDC 2001-B Limited Partnership, hereby certify that: 

- I have reviewed the Annual Report on Form 10-K of the Company (the "Report") to which this statement is an Exhibit;
- the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
- the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

_/s/ Dale G. Rettinger                       

Name: Dale G. Rettinger

Title: Chief Financial Officer

Date: __March 25, 2003_________
[Federal Register Volume 66, Number 100 (Wednesday, May 23, 2001)]
[Notices]
[Page 28533]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-12922]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant application and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institutes of Allergy and Infectious 
Diseases Special Emphasis Panel ``Peripheral Tolerance and 
Autoimmunity.''
    Date: June 13, 2001.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 6700 B Rockledge Drive, Room 2223, Bethesda, MD 20892, 
(Telephone Conference Call).
    Contact Person: Nasrin Nabavi, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, NIH, Room 2156, 6700B Rockledge Drive, MSC 7610, 
Bethesda, MD 20892-7610, 301 496-2550, <a href="/cdn-cgi/l/email-protection#335d5d000347735d5a5b1d545c45"><span class="__cf_email__" data-cfemail="b4dada8784c0f4dadddc9ad3dbc2">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


    Dated: May 15, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-12922 Filed 5-22-01; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>